Showing results (21-30 of 94) with videos related to
Sort By:
Pageof 10
Metabolism: Clinical and Experimental|June 1, 1996
The relationship between plasma insulin level, prostaglandin production by adipose tissue, and blood pressure in normal rats and rats with diabetes mellitus and diabetic ketoacidosisK Chatzipanteli, C Head, J Megerman, et al.Soft Matter|April 29, 2024
Lock-key microfluidics: simulating nematic colloid advection along wavy-walled channelsKarolina Wamsler, Louise C Head, Tyler N ShendrukThe Journal of Arthroplasty|December 14, 2001
A new method of trochanteric fixation after osteotomy in revision total hip arthroplasty with a calcar replacement femoral componentR H Emerson, W C Head, L L HigginsClinical Orthopaedics and Related Research|February 1, 1995
Titanium as the material of choice for cementless femoral components in total hip arthroplastyW C Head, D J Bauk, R H EmersonClinical Orthopaedics and Related Research|June 1, 1994
Extensor mechanism reconstruction with an allograft after total knee arthroplastyR H Emerson, W C Head, T I MalininThe Journal of Biological Chemistry|February 25, 1991
Preparation of VT1 and VT2 hybrid toxins from their purified dissociated subunits. Evidence for B subunit modulation of a subunit functionS C Head, M A Karmali, C A LingwoodSeminars in Arthroplasty|September 6, 1991
Comparison of the early healing course of porous titanium with hydroxyapatite-coated porous titanium hip implants: clinical considerations for the use of hydroxyapatite coating in total hip replacementR H Emerson, W C Head, P C PetersClinical Orthopaedics and Related Research|November 1, 1990
Reconstruction of patellar tendon rupture after total knee arthroplasty with an extensor mechanism allograftR H Emerson, W C Head, T I MalininClinical Orthopaedics and Related Research|December 28, 1999
Structural bone grafting for femoral reconstructionW C Head, R H Emerson, T I MalininCurrent Medical Research and Opinion|January 1, 1987
Long-term follow-up of 500 patients with mild to moderate hypertension who had successfully completed a 3-month general practice study of a timolol-bendrofluazide combination ('Prestim')A C Head, B T Marsh, I T FaireyPageof 10